smoothened antagonists (IRBM)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug Namesmoothened antagonists (IRBM)

Drug Alias NameHh pathway antagonists (IRBM/Merck)hedgehog pathway antagonists (IRBM/Merck)smoothened antagonists (Merck)smoothened antagonists (Istituto di Ricerche di Biologia Molecolare Pietro Angeletti)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSmoothened receptor inhibitors

TargetsSmoothened receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIrbm SPA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIrbm SPA

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A